Novo Nordisk is one of the few highly reputed pharma businesses and there is a reason for it. Rather than stick to its economistic origins that so many of its competitors live and organize by, Novo Nordisk allowed itself to experiment and react to stakeholder criticism. Rather than reactively...

The case describes the early commitment of a European pharmaceutical company, Novo Nordisk, to integrated reporting. Novo Nordisk is one of the pioneers of integrated reporting and it emerged out of its commitment to a "triple bottom line approach to managing the company." The case describes the...